UNSPSC 51173201: Bisacodyl/magnesium citrate/phenolphthalein

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA209. This VA Drug Class (GA209) classifies this compound as belonging to the group LAXATIVES, OTHER.

UNSPSC 51173201 Bisacodyl/magnesium citrate/phenolphthalein is a Commodity code that in recent state and local procurement shows no purchasing activity aligned with its nominal pharmaceutical scope. The single recent solicitation associated with the code—Collin County Community Supervision and Corrections Department's RFP 2026-327 for offender specimen collection and drug testing services—concerns controlled-substance immunoassay screening, confirmation testing (LC/MS/MS or GC/MS), and alternative testing methodologies including oral fluid and hair analysis. This work falls under clinical laboratory and forensic testing services, not laxative or bowel-preparation pharmaceuticals. The mismatch suggests either a coding error in the county's tagging of the opportunity or a divergence between the code's intended scope and its current application in state and local procurement systems.

Collin County Community Supervision and Corrections Department issued the RFP on September 25, 2026 with a response deadline of July 23, 2026 (a retroactive deadline indicating a source-data inconsistency). The contract is estimated at $600,000 over two years commencing September 1, 2026, with three optional one-year renewals, and calls for staffing two collection sites in Plano and McKinney Monday through Friday plus five Saturdays annually, operation of an Interactive Voice Response randomized-testing system, and annual testing volume of approximately 25,031 tests. Evaluation emphasizes vendor understanding, firm qualifications, client references, and cost equally (30, 25, 15, and 30 points respectively in Phase 1), with optional Phase 2 demonstrations and interviews available. The code shows no recent purchasing activity in other jurisdictions or states under its stated pharmaceutical definition.